论文部分内容阅读
The crystal structure of the title compound (C28H22ClF4N3O2 , Mr = 543.14) was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group P21 with a = 12.2113(11), b = 9.4956(9), c = 25.484(2) , β = 98.486(1)°, V = 2922.6(5) , Z = 2, Dc = 1.302 Mg/m3 , F(000) = 1184, μ = 0.19 mm-1 , R = 0.068 and wR = 0.186. The asymmetric unit of the title compound contains two organic molecules and two solvent acetone molecules with 50% occupancy each. In each organic molecule, the dihydropyridine ring adopts a half boat conformation. In the crystal, the molecules are linked by N-H···O hydrogen bonds.
The crystal structure of the title compound (C28H22ClF4N3O2, Mr = 543.14) was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group P21 with a = 12.2113 (11), b = 9.4956 , C = 25.484 (2) β, β = 98.486 (1) °, V = 2922.6 (5) , Z = 2 and Dc = 1.302 Mg / R = 0.068 and wR = 0.186. The asymmetric unit of the title compound contains two organic molecules and two solvent acetone molecules with 50% occupancy each. In each organic molecule, the dihydropyridine ring ring a half boat conformation. In the crystal, the molecules are linked by NH ··· O hydrogen bonds.